Clinical trial · Observational
Outcomes of a Deep Inferior Epigastric Perforator Flap Program
NCT00543907CI-TRIAL-00062669completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Pre programmatic development
- description
- Patients who have undergone mastectomy for breast cancer prior to implementation of the deep inferior epigastric perforator flap microsurgical breast reconstruction program
- label
- Post programmatic development
- description
- Patients who have undergone mastectomy for breast cancer after implementation of the deep inferior epigastric perforator flap microsurgical breast reconstruction program
Primary outcomes (1)
- measure
- complication rate
- timeFrame
- 6 years
- description
- complication rate
Secondary outcomes (2)
- measure
- reconstruction rate
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Intraductal carcinoma * Lobular carcinoma * Infiltrating ductal carcinoma * Paget's disease * BRCA positive Exclusion Criteria: * Inflammatory carcinoma of the breast
References
Publications (0)
Data not yet available
No reference posted for this study.